A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine

NCT01465035 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: TIV and MVA-NP+M1
BIOLOGICAL: Saline placebo and seasonal influenza vaccine TIV

Sponsor

University of Oxford